Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
As a consequence of the initial vaccine shortages in the coronavirus pandemic, the German government is securing vaccine production and supplies for the years ahead.
read more
Wednesday, December 04, 2019
Vivera Pharmaceuticals has signed an agreement with Parexel.
read more
Wednesday, February 13, 2019
Vitruvias has entered into a collaborative development agreement with Bright Future Pharmaceutical Lab to develop a portfolio of semi-solids to be marketed in the United States and China.
read more
Thursday, September 30, 2021
Southeast Asia’s first GMP-compliant CDMO for viral vector manufacturing CellVec Pte Ltd announced a strategic partnership with Australia’s Peter MacCallum Cancer Centre (Peter Mac) to manufacture and supply lentiviral vectors for their in-house ...
read more
Vindon Scientific (Ireland) Ltd. have made substantial new investment in Ireland’s only IMB certified, GMP compliant Stability Storage Facility at Tramore, County Waterford. Trebling the capacity to 350m³ has enabled Vindon to offer clients stability...
read more
Thursday, August 08, 2013
Vindon, an international company specializing in controlled storage technology for the pharma and biopharma industries, has opened a new facility in Los Angeles, Southern California.
read more
ViiV Healthcare and Halozyme Therapeutics, Inc. announced a global collaboration and license agreement that gives exclusive access to Halozyme’s ENHANZE® drug delivery technology, recombinant human hyaluronidase PH20 enzyme (rHuPH20), for specific ...
read more
Vibalogics has increased its single-use bioreactor and purification capacity with a new manufacturing line for its specialist oncolytic virus and viral vector manufacturing services.
read more
Friday, December 11, 2020
Viatris has expanded on the restructuring program announced by Mylan earlier this year.
read more
Under a license agreement with the HMRI for development of clinical grade RNA manufacturing services, VGXI announced it has completed all of the partnership’s Phase I initiatives and anticipates Phase II will conclude by 4Q 2019.
read more
With the realization of the first successful customer fills, Vetter, a leading global Contract Development and Manufacturing Organization (CDMO), has reached another milestone at its new clinical manufacturing facility in Rankweil, Austria.
read more
Vetter, a leading contract development and
manufacturing organization (CDMO), announced today that its new award-winning filling
line at the company’s Ravensburg Vetter South facility is fully validated and ready for
cGMP filling, after successful...
read more
Vetter, a leading global Contract Development and Manufacturing?Organization?(CDMO) has further?invested in additional?capacity to meet this growing global demand in Rankweil, Austria. The site has been modified to the high Vetter quality standards ...
read more
Wednesday, January 19, 2022
Vetter has received the manufacturing authorization for its new site in Rankweil, Austria. As a result of the successful inspection held by the responsible national regulatory authority, the Austrian Agency for Health and Food Safety (AGES), the site...
read more
Effective immediately, all Vetter sites in Germany will be supplied with only CO2 neutral energy from certified renewable energy sources.
read more